For the Inventor, By the Inventor

Enter assignee name

Lausanne, Switzerland

Ac Immune Sa

USPTO Granted Patents = 68

% Expired Patents = 5.9

CIPO Patents = 7

EPO Patents = 44

Trademarks = 3

Forward Citations = 307

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Andreas Muhs (33 out of 34 patents)

Andrea M Pfeifer (26 out of 36 patents)

Oskar Adolfsson (18 out of 18 patents)

4. Maria Pihlgren (17 out of 17 patents)

5. David T Hickman (13 out of 13 patents)

6. Ryan Jefferson Watts (10 out of 39 patents)

7. Isidro Hotzel (9 out of 18 patents)

8. Maria Pihlgren Bosch (9 out of 9 patents)

9. Heiko Kroth (8 out of 9 patents)

10. Marija Vukicevic Verhille (7 out of 7 patents)

11. Emanuele Gabellieri (7 out of 9 patents)

12. Gai Ayalon (7 out of 8 patents)

13. Danielle Marie Di Cara (7 out of 7 patents)

14. Wolfgang Froestl (6 out of 11 patents)

15. Fred Van Leuven (6 out of 7 patents)

Core Competencies:

Anti-Tau Antibodies

Tau Peptide Vaccine

Amyloid-Beta

Therapeutic Vaccines

Diagnostic Compounds

Humanized Antibodies

Neurofibrillary Tangles

Phosphospecific Antibodies

Supramolecular Constructs

Bicyclic Compounds

Monoclonal Antibodies

Ocular Disease

68 patents: Sort by Forward Citations

1. 12624010 - Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway (2026-05-12),

2. 12600766 - Anti-TDP-43 Binding Molecules and Uses Thereof (2026-04-14),

3. 12552800 - Compounds for diagnosis (2026-02-17),

4. 12534519 - Novel Molecules for Therapy and Diagnosis (2026-01-27),

5. 12486319 - ANTI-TAU ANTIBODIES AND METHODS OF USE (2025-12-02),

6. 12324855 - Method of safe administration of phosphorylated Tau peptide vaccine (2025-06-10),

7. 12290553 - Method for vaccination against a self-antigen in a human patient (2025-05-06),

8. 12202840 - Compounds for the treatment or alleviation of disorders associated with Tau aggregates (2025-01-21),

9. 12005102 - Anti-abeta therapeutic vaccines (2024-06-11),

10. 11958889 - Compositions of phosphorylated tau peptides and uses thereof (2024-04-16),

11. 11814378 - Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates (2023-11-14),

12. 11684625 - Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates (2023-06-27),

13. 11684576 - Method of safe administration of phosphorylated tau peptide vaccine (2023-06-27),

14. 11623931 - Bicyclic compounds for diagnosis and therapy (2023-04-11),

15. 11591377 - Heterologous administration of tau vaccines (2023-02-28),

AC Immune SA is a clinical-stage biopharmaceutical company, which develops treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. The company's unique drug discovery platform allows it to accurately target misfolded proteins associated with these diseases. AC Immune's pipeline includes a variety of candidates in different stages of development, and it collaborates with other leading pharmaceutical companies to bring innovative therapies to patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

68 Patents

#8 in Lausanne

#228 in Switzerland

#10,870 in the World

Lausanne, Switzerland

Ac Immune Sa

Forward Citations = 307

71 inventors:

Andreas Muhs (33 out of 34 patents)

Andrea M Pfeifer (26 out of 36 patents)

Oskar Adolfsson (18 out of 18 patents)

4. Maria Pihlgren (17 out of 17 patents)

5. David T Hickman (13 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…